Identification of HIST1H2BH as the hub gene associated with multiple myeloma using integrated bioinformatics analysis

References

• Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351(18):1860–1873.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Kyle RA Plasma cell disorders. In: Goldman L, Ausiello D, editors. Cecil textbook of medicine, 23rd ed. Philadelphia, PA: Saunders; 2007; 1426–1437.
   Google Scholar
• Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(8):1086–1107.
   PubMed Web of Science ®Google Scholar
• Kekre N, Connors JM. Venous thromboembolism incidence in hematologic malignancies. Blood Rev. 2019;33:24–32.
   PubMed Web of Science ®Google Scholar
• Laubach J, Richardson P, Anderson K. Multiple myeloma. Annu Rev Med. 2011;62:249–264.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. (2018). Estimated number of incident cases, both sexes, multiple myeloma, worldwide in 2013. Accessed August 31, 2018. http://gco.iarc.fr/today.
   Google Scholar
• Surveillance epidemiology and end results Fast Stats: an interactive tool for access to SEER cancer statistics, Surveillance Research Program, National Cancer Institute. Updated 2018 Accessed August 31, 2018. https://seercancergov/statfacts/.
   Google Scholar
• Liu J, Liu W, Mi L, et al. Incidence and mortality of multiple myeloma in China, 2006–2016: an analysis of the global burden of disease study 2016. J Hematol Oncol. 2019;12(1):136–142.
   PubMed Web of Science ®Google Scholar
• Gao W, Zheng Y, Zhang R, et al. Incidence of multiple myeloma in Kailuan cohort: a prospective community-based study in China. Cancer Epidemiol. 2022;78:102168–102174.
   PubMed Web of Science ®Google Scholar
• Wang S, Xu L, Feng J, et al. Prevalence and incidence of multiple myeloma in urban area in China: a national population-based analysis. Front Oncol. 2019;9:1513–1521.
   PubMed Web of Science ®Google Scholar
• Kumar SK, Rajkumar V, Kyle RA, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046–17065.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. Multiple myeloma: every year a new standard? Hematol Oncol. 2019;37(Suppl 1):62–65.
   PubMedGoogle Scholar
• Padala SA, Barsouk A, Barsouk A, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci (Basel). 2021;9(1):3–16.
   PubMedGoogle Scholar
• Eslick R, Talaulikar D. Multiple myeloma: from diagnosis to treatment. Aust Fam Physician. 2013;42(10):684–688.
   PubMedGoogle Scholar
• Barlogie B, Beck T. Recombinant human erythropoietin and the anemia of multiple myeloma. Stem Cells. 1993;11(2):88–94.
   PubMed Web of Science ®Google Scholar
• Caceres W, Santiago K, Paulo L, et al. Anemia and infections in multiple myeloma: supportive therapy. Bol Asoc Med P R. 2009;101(2):50–52.
   PubMedGoogle Scholar
• Brigle K, Rogers B. Pathobiology and diagnosis of multiple myeloma. Semin Oncol Nurs. 2017;33(3):225–236.
   PubMed Web of Science ®Google Scholar
• Yu J, Chai P, Xie M, et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22(1):85–106.
   PubMed Web of Science ®Google Scholar
• Bachmann C, Noreen F, Voermans NC, et al. Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies. Hum Mutat. 2019;40(7):962–974.
   PubMed Web of Science ®Google Scholar
• Tathe P, Chowdary K, Murmu KC, et al. SHP-1 dephosphorylates histone H2B to facilitate its ubiquitination during transcription. EMBO J. 2022;41(19):e109720–109740.
   PubMed Web of Science ®Google Scholar
• Wang L, Xu Z, Wang L, et al. Histone H2B ubiquitination mediated chromatin relaxation is essential for the induction of somatic cell reprogramming. Cell Prolif. 2021;54(8):e13080–13093.
   PubMed Web of Science ®Google Scholar
• Cole AJ, Clifton-Bligh R, Marsh DJ. Histone H2B monoubiquitination: roles to play in human malignancy. Endocr Relat Cancer. 2015;22(1):T19–T33.
   PubMed Web of Science ®Google Scholar
• Li X, Tian R, Gao H, et al. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients. Sci Rep. 2017;7(1):16495–16507.
   PubMedGoogle Scholar
• Wang Y, Wang Z, Sun J, et al. Identification of HCC subtypes with different prognosis and metabolic patterns based on mitophagy. Front Cell Dev Biol. 2021;9:799507–799522.
   PubMed Web of Science ®Google Scholar
• Seong BK, Fathers KE, Hallett R, et al. A metastatic mouse model identifies genes that regulate neuroblastoma metastasis. Cancer Res. 2017;77(3):696–706.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Shah UA, Mailankody S. Emerging immunotherapies in multiple myeloma. Br Med J. 2020;370:m3176–3194.
   PubMedGoogle Scholar
• Minnie SA, Hill GR. Immunotherapy of multiple myeloma. J Clin Invest. 2020;130(4):1565–1575.
   PubMed Web of Science ®Google Scholar
• Heider M, Nickel K, Hogner M, et al. Multiple myeloma: molecular pathogenesis and disease evolution. Oncol Res Treat. 2021;44(12):672–681.
   PubMed Web of Science ®Google Scholar
• Kastritis E, Terpos E, Dimopoulos MA. How I treat relapsed multiple myeloma. Blood. 2022;139(19):2904–2917.
   PubMed Web of Science ®Google Scholar
• Jadoon Y, Siddiqui MA. Immunotherapy in multiple myeloma. Cancer Treat Res Commun. 2021;29:100468–100478.
   PubMedGoogle Scholar
• Li D, Wang L, Cai W, et al. Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings. Eur J Radiol. 2022;151:110313–110325.
   PubMed Web of Science ®Google Scholar
• Wu F, Sun H, Shi Z, et al. Estimating microvascular invasion in patients with resectable multinodular hepatocellular carcinoma by using preoperative contrast-enhanced MRI: establishment and validation of a risk score. J Hepatocell Carcinoma. 2023;10:1143–1156.
   PubMed Web of Science ®Google Scholar
• Qu L, Wang ZL, Chen Q, et al. Prognostic value of a long non-coding RNA signature in localized clear cell renal cell carcinoma. Eur Urol. 2018;74(6):756–763.
   PubMed Web of Science ®Google Scholar
• Ye J, Liao B, Jiang X, et al. Prognosis value of platelet counts, albumin and neutrophil-lymphocyte ratio of locoregional recurrence in patients with operable head and neck squamous cell carcinoma. Cancer Manag Res. 2020;12:731–741.
   PubMed Web of Science ®Google Scholar
• Skvortsova K, Iovino N, Bogdanovic O. Functions and mechanisms of epigenetic inheritance in animals. Nat Rev Mol Cell Biol. 2018;19(12):774–790.
   PubMed Web of Science ®Google Scholar
• Xu Q, Xie W. Epigenome in early mammalian development: inheritance, reprogramming and establishment. Trends Cell Biol. 2018;28(3):237–253.
   PubMed Web of Science ®Google Scholar
• Fuchs G, Shema E, Vesterman R, et al. RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Mol Cell. 2012;46(5):662–673.
   PubMed Web of Science ®Google Scholar
• Chen S, Li J, Wang DL, et al. Histone H2B lysine 120 monoubiquitination is required for embryonic stem cell differentiation. Cell Res. 2012;22(9):1402–1405.
   PubMed Web of Science ®Google Scholar
• Shema E, Kim J, Roeder RG, et al. RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression. Mol Cell. 2011;42(4):477–488.
   PubMed Web of Science ®Google Scholar
• Lai CY, Hsieh MC, Ho YC, et al. Spinal RNF20-mediated histone H2B monoubiquitylation regulates mGluR5 transcription for neuropathic allodynia. J Neurosci. 2018;38(43):9160–9174.
   PubMed Web of Science ®Google Scholar
• Xu Z, Song Z, Li G, et al. H2b ubiquitination regulates meiotic recombination by promoting chromatin relaxation. Nucleic Acids Res 2016;44(20):9681–9697.
   PubMed Web of Science ®Google Scholar
• Minsky N, Shema E, Field Y, et al. Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat Cell Biol. 2008;10(4):483–488.
   PubMed Web of Science ®Google Scholar
• Wang SP, Ding ZX, Meng J, et al. Expression and clinical significance of HIST1H2BH in head and neck squamous cell carcinoma. Shanghai Kou Qiang Yi Xue. 2021;30(6):599–605.
   PubMedGoogle Scholar
• Takenaka K, Curry-Hyde A, Olzomer EM, et al. Investigation of transcriptome patterns in endometrial cancers from obese and lean women. Int J Mol Sci. 2022;23(19):11471–11484.
   PubMed Web of Science ®Google Scholar